227 related articles for article (PubMed ID: 26886646)
1. Prediction of Large Joint Destruction in Patients With Rheumatoid Arthritis Using 18F-FDG PET/CT and Disease Activity Score.
Suto T; Okamura K; Yonemoto Y; Okura C; Tsushima Y; Takagishi K
Medicine (Baltimore); 2016 Feb; 95(7):e2841. PubMed ID: 26886646
[TBL] [Abstract][Full Text] [Related]
2. Predictive factors associated with the progression of large-joint destruction in patients with rheumatoid arthritis after biologic therapy: A post-hoc analysis using FDG-PET/CT and the ARASHI (assessment of rheumatoid arthritis by scoring of large-joint destruction and healing in radiographic imaging) scoring method.
Suto T; Yonemoto Y; Okamura K; Okura C; Kaneko T; Kobayashi T; Tachibana M; Tsushima Y; Takagishi K
Mod Rheumatol; 2017 Sep; 27(5):820-827. PubMed ID: 27919199
[TBL] [Abstract][Full Text] [Related]
3. Semi-quantitative analysis of
Ravikanth R; Singh JK
World J Nucl Med; 2020; 19(4):347-352. PubMed ID: 33623503
[No Abstract] [Full Text] [Related]
4. Whole-body FDG-PET/CT on rheumatoid arthritis of large joints.
Kubota K; Ito K; Morooka M; Mitsumoto T; Kurihara K; Yamashita H; Takahashi Y; Mimori A
Ann Nucl Med; 2009 Nov; 23(9):783-91. PubMed ID: 19834653
[TBL] [Abstract][Full Text] [Related]
5. Demonstrating disease activity in patients with rheumatoid arthritis. Is 18F FDG PET a sensitive method?
Karapolat I; Sertpoyraz F; Oncel G; Kobak S; Yalcin M; Kumanlioglu K
Nuklearmedizin; 2013 Dec; 52(6):244-9. PubMed ID: 24081426
[TBL] [Abstract][Full Text] [Related]
6. FDG PET Imaging of Extremities in Rheumatoid Arthritis.
Dhawan R; Lokitz K; Lokitz S; Caldito G; Takalkar AM
J La State Med Soc; 2016; 168(5):156-161. PubMed ID: 27797345
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an
Lee SJ; Jeong JH; Lee CH; Ahn BC; Eun JS; Kim NR; Kang JW; Nam EJ; Kang YM
Arthritis Rheumatol; 2019 Aug; 71(8):1232-1240. PubMed ID: 30771237
[TBL] [Abstract][Full Text] [Related]
8. [18F]fluorodeoxyglucose uptake as a predictor of large joint destruction in patients with rheumatoid arthritis.
Yonemoto Y; Okamura K; Takeuchi K; Kaneko T; Kobayashi T; Okura C; Tsushima Y; Takagishi K
Rheumatol Int; 2016 Jan; 36(1):109-15. PubMed ID: 26232929
[TBL] [Abstract][Full Text] [Related]
9. (18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.
Watanabe T; Takase-Minegishi K; Ihata A; Kunishita Y; Kishimoto D; Kamiyama R; Hama M; Yoshimi R; Kirino Y; Asami Y; Suda A; Ohno S; Tateishi U; Ueda A; Takeno M; Ishigatsubo Y
Mod Rheumatol; 2016; 26(2):180-7. PubMed ID: 26140472
[TBL] [Abstract][Full Text] [Related]
10. Does periodontitis affect the treatment response of biologics in the treatment of rheumatoid arthritis?
Tachibana M; Yonemoto Y; Okamura K; Suto T; Sakane H; Kaneko T; Dam TT; Okura C; Tajika T; Tsushima Y; Chikuda H
Arthritis Res Ther; 2020 Jul; 22(1):178. PubMed ID: 32711580
[TBL] [Abstract][Full Text] [Related]
11. The assessment of biologic treatment in patients with rheumatoid arthritis using FDG-PET/CT.
Okamura K; Yonemoto Y; Arisaka Y; Takeuchi K; Kobayashi T; Oriuchi N; Tsushima Y; Takagishi K
Rheumatology (Oxford); 2012 Aug; 51(8):1484-91. PubMed ID: 22513145
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of tocilizumab therapy in patients with rheumatoid arthritis based on FDG-PET/CT.
Okamura K; Yonemoto Y; Okura C; Higuchi T; Tsushima Y; Takagishi K
BMC Musculoskelet Disord; 2014 Nov; 15():393. PubMed ID: 25417119
[TBL] [Abstract][Full Text] [Related]
13. Axillary lymph-node metabolic activity assessment on
Dam TT; Okamura K; Nakajima T; Yonemoto Y; Suto T; Arisaka Y; Tomonaga H; Tachibana M; Tajika T; Vu LD; Chikuda H; Tsushima Y
Scand J Rheumatol; 2020 Mar; 49(2):96-104. PubMed ID: 31578102
[No Abstract] [Full Text] [Related]
14. Development and validation of a new radiographic scoring system to evaluate bone and cartilage destruction and healing of large joints with rheumatoid arthritis: ARASHI (Assessment of rheumatoid arthritis by scoring of large joint destruction and healing in radiographic imaging) study.
Kaneko A; Matsushita I; Kanbe K; Arai K; Kuga Y; Abe A; Matsumoto T; Nakagawa N; Nishida K
Mod Rheumatol; 2013 Nov; 23(6):1053-62. PubMed ID: 23624939
[TBL] [Abstract][Full Text] [Related]
15. High-resolution (18)F-FDG PET/CT for assessing disease activity in rheumatoid and psoriatic arthritis: findings of a prospective pilot study.
Chaudhari AJ; Ferrero A; Godinez F; Yang K; Shelton DK; Hunter JC; Naguwa SM; Boone JM; Raychaudhuri SP; Badawi RD
Br J Radiol; 2016 Jul; 89(1063):20160138. PubMed ID: 27109738
[TBL] [Abstract][Full Text] [Related]
16. Articular
Ferraz-Amaro I; Sheikh A; Polack B; Giles JT; Bathon JM
J Rheumatol; 2022 Dec; 49(12):1315-1319. PubMed ID: 35970536
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of 18F-fluorodeoxyglucose uptake parameters to differentiate rheumatoid arthritis from other types of arthritis.
Bhattarai A; Nakajima T; Sapkota S; Arisaka Y; Tokue A; Yonemoto Y; Tsushima Y
Medicine (Baltimore); 2017 Jun; 96(25):e7130. PubMed ID: 28640086
[TBL] [Abstract][Full Text] [Related]
18. F-18 FDG whole-body PET for the assessment of disease activity in patients with rheumatoid arthritis.
Goerres GW; Forster A; Uebelhart D; Seifert B; Treyer V; Michel B; von Schulthess GK; Kaim AH
Clin Nucl Med; 2006 Jul; 31(7):386-90. PubMed ID: 16785804
[TBL] [Abstract][Full Text] [Related]
19. 2-Deoxy-2-[F-18]fluoro-D-glucose joint uptake on positron emission tomography images: rheumatoid arthritis versus osteoarthritis.
Elzinga EH; van der Laken CJ; Comans EF; Lammertsma AA; Dijkmans BA; Voskuyl AE
Mol Imaging Biol; 2007; 9(6):357-60. PubMed ID: 17902022
[TBL] [Abstract][Full Text] [Related]
20.
Li TY; Lin LF; Pan RY; Cheng SN; Wu YT; Chen LC; Chen YC
Haemophilia; 2023 Mar; 29(2):640-647. PubMed ID: 36580375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
